Long

$ACB: Buy the dip for further upside!

Mis à jour
An update. See you all at the top!

An analysis, not an investment advice.
Trade SAFE, trade PATIENTLY & say NO to GREED.
Note
ACB filed for 750 million shares to be added. Very unexpected and questionable by the company. We may see a further pullback.
Note
Up we go! ACB has been selected by the German Bundesinstitut für Arzneimittel und Medizinprodukte BfArM as one of three winners in the public tender to cultivate and distribute medical cannabis in Germany.
ACBauroracannabisichimokukinkohyoTechnical IndicatorsTrend Analysis

Publications connexes

Clause de non-responsabilité